Company intelligence / Profile preview

E2MC Ventures

Orlando, Florida, United Statese2mc.space ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

E2MC Ventures is an active venture capital firm specializing in early-stage investments in the space sector and deep tech industries globally. While its primary focus lies outside traditional healthcare or biotech, it has invested in innovative life sciences startups leveraging space-based technologies—such as LambdaVision’s protein-based artificial retina for retinal degenerative diseases. The firm supports founders with domain expertise and global networks across industry, academia, and government.

Therapeutic areas: Ophthalmology
Modalities: Protein-based therapiesBiotech platforms
Industry: Investors

Partnerships

ISS National Lab (for startup accelerators)Aurelia Foundry Fund/MIT (co-investor)Boryung Pharma (co-investor)

Beyond the preview

Go deeper on E2MC Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E2MC Ventures.

Explore the full profile